Tarek Hassan

Company: Aviceda Therapeutics

Job title: Chief Development Officer

Seminars:

Panel Discussion – The Current Landscape of Dry AMD Therapeutics 8:00 am

Reviewing complement inhibition as a means of treating dry AMD Outlining the promise of small molecule, cell therapy, stem cell therapy and gene therapy What is the earliest stage of AMD feasible for a clinical trial?Read more

day: Day One